Needle Assembly Sterile Seal via Welded Closure

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing needle assemblies for prefilled injection syringes often face challenges in maintaining a sterile seal during production and handling, with known systems either being complex or risking microbiological contamination due to releasable connections.

Innovation Solution

A non-releasable sterile barrier is created between the closure element and the needle shielding sheath using bonding or welding techniques, such as ultrasonic or laser welding, ensuring a secure and tamper-proof seal.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If a releasable connector is used between closure element and needle shielding sheath, then assembly and disassembly is simplified, but sterile seal reliability deteriorates due to risk of loosening during shipment or handling

Engineering Contradiction:
Improveassembly and disassemblyVSAvoidsterile seal
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The closure element is pre-assembled with the needle shielding sheath in a sterile environment before final product assembly. This preliminary assembly ensures the sterile barrier is established early and maintained throughout subsequent handling and shipping processes, eliminating the risk of contamination from later connection operations.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

A sterile barrier (such as a sterile drape or seal) is introduced as an intermediary between the closure element and needle shielding sheath during assembly. This barrier maintains sterility during the connection process and can be designed to remain in place during shipping, preventing contamination while allowing controlled access when needed.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of manufacture

If a snap-action connector is used to achieve releasable connection, then assembly is simplified, but sterile seal reliability deteriorates because the connector cannot assure microbiological shield

Engineering Contradiction:
Improveassembly simplicityVSAvoidmicrobiological contamination
Core Design Contradiction:
Ease of manufactureVSObject-affected harmful factors

Solution Approach 1:

The closure element and needle shielding sheath are assembled in a sterile environment before final product assembly, establishing the sterile barrier early. This preliminary action ensures that the connection is made under controlled sterile conditions, preventing microbiological contamination while maintaining assembly simplicity.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

A disposable sterile barrier or seal is used between the closure element and needle shielding sheath. This single-use component ensures sterility during assembly and shipping, then is discarded or activated when the product is ready for use, eliminating the need for complex reusable sterile mechanisms.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Stability of the object's composition

If axially staggered ribs are used to connect housing and needle hub, then secure location is achieved, but sterile seal reliability deteriorates as microbiological seal is not assured

Engineering Contradiction:
Improvesecure locationVSAvoidsterile seal
Core Design Contradiction:
Stability of the object's compositionVSReliability

Solution Approach 1:

The connection between housing and needle hub is established in a sterile environment before final assembly, with the sterile barrier already in place. This preliminary action ensures that the mechanical connection (via axially staggered ribs) does not compromise sterility, as the barrier is already sealed during the connection process.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

A sterile barrier is introduced as an intermediary between the housing and needle hub connection points. This barrier allows the axially staggered ribs to provide secure mechanical location while the barrier itself maintains the sterile seal, preventing microbiological contamination despite the mechanical connection design.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution ensures the needle remains sterile from sterilization to use, simplifies production and assembly, and provides a cost-effective, tamper-proof sterile seal for the needle assembly.

Implementation Method 1

The closure connection between the closure element and the needle shielding sheath being configured as a non-releasable and sterile barrier produced by means of a bonding or welding technique. Advantageous further embodiments of the invention read from the sub-claims. Thus, the sterile barrier is preferably a closure connection produced by ultrasonic or laser welding.

Methodology Applied
Scientific EffectUltrasonic welding: Ultrasonic Vibration

Implementation Method 2

Thus, the sterile barrier is preferably a closure connection produced by ultrasonic or laser welding.

Methodology Applied
Scientific EffectLaser welding: Laser Beam Welding

Implementation Method 3

Where a bonded connection finds application it is recommended to use non-toxic, acrylic-based adhesives for curing by means of UV light or at room temperature, such as e.g. adhesive type LOCTITE® 3011

Methodology Applied
Scientific EffectPhotopolymerisation: Photopolymerisation

Data Source

PatentUS9358346B2Needle assembly for a prefilled syringe system
Publication Date: 2016.06.07 CILAG GMBH INTERNATIONAL
  • US9358346B2 patent drawing
  • US9358346B2 patent drawing
  • US9358346B2 patent drawing

AI summary

A needle assembly (10; 210) for a prefilled injection syringe is described. A needle holder (12; 212) has a needle (14; 214) secured to it and is adapted to be secured to a syringe barrel of the injection syringe. A needle sheath (16; 216) has a distal end forming a releasable sterile seal with the needle holder (12; 212), and surrounds and shields the needle (14; 214). A needle seal (18; 218) surmounts the needle tip and is arranged at least in part in the proximal end of the needle sheath (16; 216) and closed off by a closure element (20; 220). A closure connection between the closure element (20; 220) and the needle sheath (16; 216) is configured as a non-releasable and sterile barrier (54; 254) produced by means of bonding or welding.